Refresh
Gainers Losers Sectors Indices Forex Mutual Funds

Techno Forge Ltd.

Price on BSE   09 Feb,15:33 LIVE
11.10
-0.45
(-3.90%)

© 2026 Rediff.com
  • Volume :
  • 1,000.00
  • Prev Close :
  • 11.55
  • Day's H/L (Rs.) :
  • 11.10 - 11.10
  • 52wk H/L (Rs.) :
  • 11.55 - 10.55
  • Mkt Cap (Rs. Cr) :
  • 4.78
Techno Forge Ltd. is not listed on NSE

© 2026 Rediff.com
Report Card - Techno Forge Ltd.
PE Ratios
EPS (Rs.)
-22.66
Sales (Rs. Cr)
2.28
Face Value (Rs.)
10
Net Profit Margin(%)
-191.51
Last Bonus
-
Last Dividend(%)
-
Return on Average Equity

News for Engineering

Carbon Trading Platform Launching in India by Sept
India's carbon trading platform is expected to be functional by September, boosting renewable energy transition and C&I segments.
Feb 26, 2026 15:15
JSW Motors & Tata IIS Partner for Tech Talent
JSW Motors partners with Tata IIS to build a technical talent pipeline for its EV manufacturing plant in Maharashtra.
Feb 26, 2026 15:10
Alembic Pharma Gets USFDA Nod for Generic Drug
Alembic Pharma receives USFDA approval for generic Lamotrigine tablets, used to treat seizures. ANDA equivalent to GlaxoSmithKline's Lamictal.
Feb 26, 2026 14:51
Acerpure Eyes Emerging Markets After India Success
Acerpure plans to expand to Philippines, Vietnam, Thailand, and Indonesia after success in India. Focus on local manufacturing and investment.
Feb 26, 2026 14:49
Gushwork AI Raises Rs 81 Cr Funding
Gushwork AI secures Rs 81 cr funding led by Susquehanna Asia VC. Plans to invest in AI product development, talent & customer acquisition.
Feb 26, 2026 14:48

More News »

Top News

Carbon Trading Platform Launching in India by Sept
India's carbon trading platform is expected to be functional by September, boosting renewable energy transition and C&I segments.
Feb 26, 2026 15:15
JSW Motors & Tata IIS Partner for Tech Talent
JSW Motors partners with Tata IIS to build a technical talent pipeline for its EV manufacturing plant in Maharashtra.
Feb 26, 2026 15:10
Alembic Pharma Gets USFDA Nod for Generic Drug
Alembic Pharma receives USFDA approval for generic Lamotrigine tablets, used to treat seizures. ANDA equivalent to GlaxoSmithKline's Lamictal.
Feb 26, 2026 14:51
Acerpure Eyes Emerging Markets After India Success
Acerpure plans to expand to Philippines, Vietnam, Thailand, and Indonesia after success in India. Focus on local manufacturing and investment.
Feb 26, 2026 14:49
Gushwork AI Raises Rs 81 Cr Funding
Gushwork AI secures Rs 81 cr funding led by Susquehanna Asia VC. Plans to invest in AI product development, talent & customer acquisition.
Feb 26, 2026 14:48

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com